GlassScriptPhysician profile
Veronica Smith
NPI 1619566304
$1,783.78
in general payments reported to CMS, 2019-2025
11 companies · $329 in 2025
The $329 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $943 · 2024: $512 · 2025: $329.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,784.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,783.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $358.76 | 2023-2024 | Austedo Xr |
| Dexcom, INC. | $289.52 | 2023-2025 | Dexcom G7 Gss (161), Dexcom Stelo Glucose Biosensor, Dexcom G6 Transmitter |
| Abbvie INC. | $222.30 | 2023-2025 | |
| Evofem Biosciences, INC. | $155.70 | 2023-2025 | Phexxi, Solosec, Phexx |
| Sumitomo Pharma America, INC. | $125.00 | 2023 | Gemtesa |
| Neurelis, INC. | $123.56 | 2024 | Valtoco |
| Novo Nordisk INC | $121.81 | 2023 | Wegovy |
| Idorsia Pharmaceuticals US INC | $120.39 | 2023 | Quviviq |
| Janssen Pharmaceuticals, INC | $115.06 | 2024 | Spravato |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $100.00 | 2023 | Lifevest |
| Exact Sciences Corporation | $51.68 | 2023 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Veronica Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.